title: Trophoblastic disease review for diagnosis and management: a joint report from the International Society for the Study of Trophoblastic Disease, European Organisation for the Treatment of Trophoblastic Disease, and the Gynecologic Cancer InterGroup.
abstract: OBJECTIVE
  The objective of this study was to provide a consensus review on gestational trophoblastic disease diagnosis and management from the combined International Society for the Study of Trophoblastic Disease, European Organisation for the Treatment of Trophoblastic Disease, and the Gynecologic Cancer InterGroup.
  
  
  METHODS
  A joint committee representing various groups reviewed the literature obtained from PubMed searches.
  
  
  CONCLUSIONS
  Guidelines were constructed on the basis of literature review. After initial diagnosis in local centers, centralization of pathology review and ongoing care is recommended to achieve the best outcomes.
authors.affiliation: *Department of Gynecology and Obstetrics, IRCCS San Raffaele Hospital, Milan, Italy; †Gynecologic Oncology Department, Catholic University of the Sacred Heart, Rome/Campobasso, Italy; ‡Gynecologic Oncology Group, The University of Texas MD Anderson Cancer Center, Houston, TX; §AGO Study Group, Gynecologic Oncology Center, Kiel, Germany; ∥Department of Obstetrics and Gynaecology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; ¶ANZGOG, Camperdown, New South Wales, Australia; #Department of Obstetrics and Gynecology, University of Hong Kong, Queen Mary Hospital, Hong Kong, People's Republic of China; **Centre de Référence des Maladie Trophoblastiques, Hospices Civils de Lyon, Lyon, France; ††Department of Obstetrics and Gynecology, Institute of Maternal and Child Health, Medical College, Calicut, India; ‡‡GTD unit, University Hospital of Caracas, Central University of Venezuela, Caracas, Venezuela; §§The Spanish Ovarian Cancer Research Group (GEICO), Fundación Instituto Valenciano de Oncología, Valencia, Spain; ∥∥Korean Gynaecologic Oncology Group, Seoul National University Hospital, Seoul, South Korea; ¶¶Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China; ##Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and ***Charing Cross Trophoblastic Disease Centre, Departments of Histopathology and Medical Oncology, Charing Cross Campus of Imperial College London, London, United Kingdom.
authors.forename: Giorgia
authors.initials: G
authors.lastname: Mangili
authors.forename: Domenica
authors.initials: D
authors.lastname: Lorusso
authors.forename: Jubilee
authors.initials: J
authors.lastname: Brown
authors.forename: Jacobus
authors.initials: J
authors.lastname: Pfisterer
authors.forename: Leon
authors.initials: L
authors.lastname: Massuger
authors.forename: Michelle
authors.initials: M
authors.lastname: Vaughan
authors.forename: Hextan Y S
authors.initials: HY
authors.lastname: Ngan
authors.forename: Francois
authors.initials: F
authors.lastname: Golfier
authors.forename: Paradan K
authors.initials: PK
authors.lastname: Sekharan
authors.forename: Rafael Cortés
authors.initials: RC
authors.lastname: Charry
authors.forename: Andres
authors.initials: A
authors.lastname: Poveda
authors.forename: Jae-Weon
authors.initials: JW
authors.lastname: Kim
authors.forename: Yang
authors.initials: Y
authors.lastname: Xiang
authors.forename: Ross
authors.initials: R
authors.lastname: Berkowtiz
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Seckl
mesh_terms: D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007390:International Agencies; D008495:Medical Oncology; D012955:Societies, Medical; D014328:Trophoblastic Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D014594:Uterine Neoplasms / Q000175:diagnosis* / Q000628:therapy*